Trial Information

Summary: Migraine Headache Trial Now Accepting Volunteers

Physicians at the University of Kentucky Gill Heart Institute and the Kentucky Clinic Department of Neurology are now participating in a national research study to determine if Patent Foramen Ovale (PFO) closure using the AMPLATZER device can prevent migraine headaches compared to standard medical therapy.

You may be eligible for this research study if you:

• are an adult between 18 and 55 years of age;
• have severe migraine headaches.

Qualified volunteers will receive:

• free evaluation by a migraine neurologist;
• free screening for Patent Foramen Ovale (PFO);
• opportunity for PFO closure at no cost.

The research study will require a minimum of eleven clinic visits during the first year and then one clinic visit a year for a minimum of five years. The first visit requires at least a 24 hour overnight hospital stay. Follow-up visits will take one to two hours each.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:37 AM